NO20090163L - Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans - Google Patents

Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans

Info

Publication number
NO20090163L
NO20090163L NO20090163A NO20090163A NO20090163L NO 20090163 L NO20090163 L NO 20090163L NO 20090163 A NO20090163 A NO 20090163A NO 20090163 A NO20090163 A NO 20090163A NO 20090163 L NO20090163 L NO 20090163L
Authority
NO
Norway
Prior art keywords
active substance
poorly water
soluble active
preparations including
combination preparations
Prior art date
Application number
NO20090163A
Other languages
English (en)
Inventor
Henricus R M Gorissen
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20090163L publication Critical patent/NO20090163L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen er relatert til en oral sammensetning av benzazepin-1-eddiksyrederivater omfattende a) nevnte aktive forbindelse i en mengde på mellom I 0 og 65 % av den totale vekten av formuleringen; b) minst 10 vekt-% av en alkalisk forbindelse eller en blanding av alkaliske forbindelser; c) omfatter eventuelt hjelpematerialer i en mengde på mellom I% og 45 % av den totale vekten av formuleringen. Oppfinnelsen er videre relatert til den ovenfor definerte orale sammensetningen omfattende natriumkarbonat med en spesifikk partikkelstørrelse og/eller overflateareal som alkalisk forbindelse.
NO20090163A 2006-06-16 2009-01-12 Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans NO20090163L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81407606P 2006-06-16 2006-06-16
EP06115582 2006-06-16
PCT/EP2007/055937 WO2007144418A1 (en) 2006-06-16 2007-06-15 Oral pharmaceutical composition of a poorly water-soluble active substance

Publications (1)

Publication Number Publication Date
NO20090163L true NO20090163L (no) 2009-01-14

Family

ID=38475902

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090163A NO20090163L (no) 2006-06-16 2009-01-12 Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans

Country Status (10)

Country Link
EP (1) EP2034967B1 (no)
JP (1) JP2009539940A (no)
KR (1) KR20090032085A (no)
AT (1) ATE509620T1 (no)
AU (1) AU2007259252A1 (no)
CA (1) CA2654111A1 (no)
EA (1) EA014898B1 (no)
IL (1) IL195531A0 (no)
NO (1) NO20090163L (no)
WO (1) WO2007144418A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2753129T3 (es) * 2011-12-09 2020-04-07 Merck Patent Gmbh Carbonato de sodio libre de agua, con bajo contenido en poros

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
TW200633713A (en) * 2004-12-23 2006-10-01 Solvay Pharm Bv Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders

Also Published As

Publication number Publication date
AU2007259252A1 (en) 2007-12-21
EA200970020A1 (ru) 2009-06-30
IL195531A0 (en) 2009-09-01
EA014898B1 (ru) 2011-02-28
WO2007144418A1 (en) 2007-12-21
ATE509620T1 (de) 2011-06-15
JP2009539940A (ja) 2009-11-19
EP2034967A1 (en) 2009-03-18
KR20090032085A (ko) 2009-03-31
CA2654111A1 (en) 2007-12-21
EP2034967B1 (en) 2011-05-18

Similar Documents

Publication Publication Date Title
TR201906970T4 (tr) Fenilefrin ihtiva eden sıvı formülasyonlar.
PE20080123A1 (es) Composiciones farmaceuticas que contienen vx-950 en el tratamiento de hepatitis c
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
ATE219659T1 (de) Verwendung gelierbarer pharmazeutischer zusammensetzungen in der parodontologie
UA100966C2 (ru) Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей
DE602005025755D1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
CR9626A (es) Formas de dosificacion de liberacion retardada oral altamente biodisponible de un o-desmetilvenlafaxin succinato
AR061134A1 (es) Derivados de tioxantina
BRPI0518781A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, e, uso de um composto
WO2008065097A3 (en) Stabilized solid pharmaceutical composition of candesartan cilexetil
RS53548B1 (en) THERAPEUTIC FORMULATIONS OF KERATINocyte GROWTH FACTORS
RS53554B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 2-OXO-1-PYROLIDINE DERIVATIVES
HRP20110162A8 (hr) Spojevi koji sadrže amlodipin i bisoprolol
BR0307278A (pt) Formulação oral de liberação imediata, e, método para preparar uma formulação
NO20063858L (no) Antimikrobielle preservativer for oppnaelse av en multidoseformulering ved bruk av beta-cyklodekstriner for flytende doseringsformer
WO2008056375A3 (en) Pharmaceutical formulations comprising valsartan
ATE528009T1 (de) Reepithelialisierende pharmazeutische zusammensetzungen, die xanthangummi enthalten
DE60319707D1 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
UA90700C2 (ru) Оральная композиция немедленного выделения на основе слабоводорастворимого действующего вещества
NO20090163L (no) Kombinasjonsfremstillinger innbefattende en darlig vannopploselig aktiv substans
WO2005120584A3 (en) Radiolabeled arylsulfonyl compounds and uses thereof
NO20064834L (no) Forlenget frigivelse av sammensetninger som omfatter torasmid og en matriksdannende polymer.
TW200626175A (en) Stabilized leukotriene B4 (LTB4) agent pharmaceutical formulation
UA93540C2 (ru) Фармацевтическая композиция для аэрозольного распыления c двумя действующими веществами и, по меньшей mepe, одним поверхностно-активным веществом
BRPI0713424A2 (pt) composição farmacêutica oral de um composto ativo fracamente solúvel em água, e, método para sua preparação

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application